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A B S T R A C T
The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in
regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in
that it describes a sequence of measurable key events triggered by a molecular initiating event in which a
stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular,
structural and functional changes in biological systems, resulting in a measurable adverse outcome.
Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a
basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis
for qualitative and quantitative predictive modeling of the human adverse outcome resulting from
molecular initiating or other key events for which higher-throughput testing methods are available or can
be developed.
A variety of cellular and molecular processes are known to be critical for normal function of the central
(CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the
CNS and PNS, it has been challenging to establish causative links and quantitative relationships between
key events that comprise the pathways leading from chemical exposure to an adverse outcome in the
nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or
putative adverse outcome pathways speciﬁc for developmental or adult neurotoxicity are summarized
and aspects of their assessment considered. Their possible application in developing mechanistically
informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.
ã 2016 Published by Elsevier B.V.
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NeuroToxicology1. Introduction
Modes of Action (MOA) and Adverse Outcome Pathways (AOPs)
describe mechanistic knowledge at varying levels of biological
organization to facilitate its assimilation, integration and evalua-
tion for research and regulatory applications. While conceptually
similar, MOA includes chemical related key events (KEs) such as
metabolism, whereas AOPs are restricted to the biological cascade
of KEs resulting from perturbation by a stressor. Thus, AOPs
describe a sequence of measurable KEs originating from a* Corresponding author.
E-mail address: anna.price@ec.europa.eu (A. Bal-Price).
1 Environment Health and Safety Division, Environment Directorate, Organisa-
tion for Economic Co-operation and Development (OECD), Paris, France.
http://dx.doi.org/10.1016/j.neuro.2016.05.010
0161-813X/ã 2016 Published by Elsevier B.V.
Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10molecular initiating event (MIE) resulting in cellular, structural
and functional changes and ultimately measurable adverse out-
comes (AOs) relevant to the human organism and the human
population.
Recent international developments are anticipated to contrib-
ute to increasing collective conﬁdence in applying AOPs for both
regulatory risk assessment and research. These include an update
of the World Health Organization/International Programme on
Chemical Safety (IPCS) mode of action/human relevance (MOA/HR)
framework. The modiﬁed framework is incorporated within an
iterative roadmap, encouraging continuous reﬁnement of problem
formulation and MOA-based (integrated) testing and assessment
strategies, with increasing reliance on in vitro methods at lower
levels of biological organization in preliminary assessment and
testing strategies. Weight of evidence (WoE) considerations forlying the adverse outcome pathway concept for understanding and
16/j.neuro.2016.05.010
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more recently evolved as a basis for contributing to the revision of
guidance and electronic tools for an international knowledge base
of AOPs, which was developed for an initiative of the Organization
for Economic Cooperation and Development (OECD). These
advances in considering weight of evidence as a basis to increase
consistency and conﬁdence in potential applications of AOPs are
summarized and illustrated by examples for developmental or
adult neurotoxicity. Possible application in developing mechanis-
tically informed Integrated Approaches to Testing and Assessment
(IATA) is also discussed.
1.1. The need for mechanistically based testing and assessment
There is growing recognition of the need for more efﬁcient
methods and strategies to assess the hazards, exposures and risks of
the wide array of chemicals to which humans are exposed. This has
been reﬂected in, among others, progressive regulatory mandates in
Canada, the European Union and, more recently, the Asian Paciﬁc
region, to systematically consider priorities for risk management for
existingchemicals (see, forexample, Council of LaborAffairs, Taiwan,
2012; Dellarco et al., 2010; European Commission, 2006; Hughes
et al., 2009; Lowell Center for Sustainable Production, 2012; Meek
and Armstrong, 2007). This necessitates focus on rationally
prioritized chemicals and endpoints, rather than the traditional
time- and resource-intensive series of standard in vivo toxicology
studies. It also requires the development and integration of
information on KEs that will enable effective use of data collected
from lower levels of biological organization and non-test methods,
such as (quantitative) structure–activity relationships ((Q)SAR) and
read-across relationships based on in vitro assays.
1.2. Evolution of MOA analysis
MOA, as previously deﬁned, is a biologically plausible series of
KEs leading to an effect (Sonich-Mullin et al., 2001) which has
traditionally, been considered in the context of speciﬁc chemicals
and/or chemical groups. Formal MOA/HR (mode of action/human
relevance) analysis is designed to increase transparency in the
systematic consideration of the WoE of hypothesized MOA(s) for
critical effects and their relevance to humans. An associated
framework was developed in response to initiatives of the
International Life Sciences Institute Risk Sciences Institute (ILSI
RSI) and the IPCS, and derives from earlier work on MOA by the U.S.
Environmental Protection Agency (USEPA, 2005) and IPCS (Sonich-
Mullin et al., 2001).
The development and evolution of the IPCS ILSI RSI MOA/HR
framework is described in several publications (Boobis et al., 2006;
Boobis et al., 2008; Meek, 2008; Meek et al., 2003; Seed et al.,
2005). Though developed principally to encourage the systematic
application of mechanistic data in hazard characterization, risk
assessment and identiﬁcation of associated critical data gaps, more
recently its use for a broader range of research and predictive
contexts has also been considered (Carmichael et al., 2011; Meek
and Klaunig, 2010). The framework is illustrated by an increasing
number of case studies (n = 30, currently), and is widely adopted in
international and national guidance and assessments (Meek et al.,
2008). Building on this experience, the framework has been
updated recently to address uncertainty and to extend its utility to
emerging areas in toxicity testing and non-testing methods by
increasing understanding of its role in integrating information
from different levels of biological organization. The update
includes incorporation within a roadmap, encouraging continuous
reﬁnement of ﬁt-for-purpose testing strategies and hazard
characterization (Meek et al., 2014a).Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.101.3. Weight of evidence (WoE) in MOA analysis
The WoE forhypothesized MOAs in animals is addressed based on
aspeciﬁedsubsetofconsiderationsmodiﬁedfromthoseproposedby
Bradford Hill (B/H) for assessment of causality in epidemiological
studies (Hill, 1965). To promote consistency in their application,
deﬁning questions and the nature of supporting data for each of the
relevant considerations has been additionally delineated (Meek
et al., 2014b). The modiﬁed considerations have also been rank
ordered to reﬂect evolving experience concerning their relative
contribution to WoE determinations (Meek et al., 2014b).
The approach provides for transparent and consistent framing
of comparative WoE for contrasting hypotheses for overall data
synthesis and evaluation of sufﬁciency, as a basis to support
regulatory decision making. As such, it represents perhaps the only
(or one of a very few) frameworks designed to formally address
transparency and consistency of higher level analysis involving
assimilation and weighting of data from different lines of evidence
(e.g., epidemiological, toxicological, mechanistic) based on deﬁned
a priori considerations to address critical aspects of options
analysis for decision making.
In MOA analysis, human relevance or species concordance is
also systematically considered, taking into account more
generic information such as anatomical, physiological and
biochemical variations. Application of the framework, involves:
(1) delineation of KEs leading to the end (adverse) effect in a
hypothesized MOA; (2) comparative systematic evaluation of
the extent of the supporting WoE from toxicological and
mechanistic studies for different hypotheses (Meek et al.,
2014b); and (3) systematic consideration of the likely impli-
cations for hazard in humans (both qualitative and quantitative)
based on hypothesized KEs. This analysis provides the founda-
tion for subsequent considerations of chemical-speciﬁc dose-
response and estimates of risk.
1.4. AOPs and knowledge base
More recently, the AOP concept has emerged from the ﬁeld of
ecotoxicology as a means to enhance the utility of QSAR modelling,
biomarkers and other types of mechanistic data for both
understanding and predicting potential adverse effects of chemical
exposure in wildlife populations (Ankley et al., 2010). While
experience in MoA analysis focused principally on later stages of
cellular, biochemical and tissue events, the AOP focus of the eco-
toxicological community (consistent with that in QSAR modelling)
was on the chemically mediated MIE (equivalent to an early KE in a
MOA) and AOs. They have evolved more recently to encompass
only the non-chemical speciﬁc KEs (i.e., the biological process
tripped by interaction of any stressor with an organism) to
toxicodynamic KEs in a chemical speciﬁc MOA.
AOPs have been adopted within an international initiative to
assimilate mechanistic information relevant to development of
potentially predictive tools for adverse ecological and human
health effects (OECD, 2013). The premise of the construct is that
toxicity is the result of generalizable motifs of biological failure
initiated by the interaction of a chemical with some biomolecule in
the body. This molecular interaction elicits a perturbation in
normal biology that ultimately impairs critical function of the
organism leading to toxicity and eventually impacts on the
population of concern (Edwards et al., 2016). Consequently, AOPs
are described by identifying measurable KEs at varying levels of
biological organization beginning with molecular interactions of
the chemical with the biological system and proceeding through
the organismal responses that impact populations (Villeneuve
et al., 2014). They are anchored at one end by a MIE and at the otherlying the adverse outcome pathway concept for understanding and
16/j.neuro.2016.05.010
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toxicity) or population.
An essential component of the OECD program is a knowledge
base (KB) to document AOPs, which will comprise four indepen-
dent modules that are connected via an underlying data hub. The
module that is currently most developed, the AOP-Wiki (http://
aopwiki.org), was released in September 2014 to support formal
AOP development by capturing supporting evidence in prose
format. Additional envisaged components, Effectopedia (http://
effectopedia.org/) and AOPXplorer (http://aopxplorer.org/),
expected to be released by February 2016, will capture related
information such as quantitative response-response relationships
between KEs, and relevant assays to measure KEs and collect AOP
networks from automated processes. A fourth envisaged module,
the Intermediate Effects Data Base, will connect the AOP-KB to
chemical speciﬁc information in the OECD Chemical Screening
Information Data Sets (SIDS) database (http://webnet.oecd.org/
HPV/UI/Search.aspx) via the International Uniform ChemicaL
Information Database (IUCLID) software (http://iuclid.eu). An
important objective of the knowledge base is to provide a
repository of information across different levels of biological
organization in a construct that informs both research and
regulatory objectives.
1.5. Interface of MOA analysis and AOPs
The terms MOA and AOP are, then, conceptually similar,
representing essentially the subdivision of the pathway between
exposure and effect in either individuals or populations into a
series of hypothesized KEs at different levels of biological
organization (e.g., molecular, subcellular, cellular, tissue). Both
represent pragmatic simpliﬁcations of complex biological path-
ways. The distinction between the two has been somewhat
artiﬁcial, a result principally of experience with different types of
data in the human health versus ecological communities.
However, the AOP concept has evolved recently to encompass
only chemical agnostic KEs resulting from perturbations of normal
biology between MIEs and adverse effects. As such, they identify
KEs at various levels of biological organization for which associated
assays or computational models may be helpful in predicting
adverse effects. This is a welcome development in that it is
anticipated to facilitate collective contribution to knowledge of
networks in systems biology. Quantiﬁcation of relationships
between key events (KERs) is anticipated to contribute to
prediction of the extent of biological response. As a result, while
AOPs are often developed and documented based on supporting
information that includes challenge by reference chemicals, they
draw collectively upon such data solely as a basis to deﬁne
biological pathways rather than the assessment of individual (e.g.,
chemical) stressors (Edwards et al., 2016).
While AOPs can be used for different purposes, one common
application is their integration as the toxicodynamic KEs in a
hypothesized MOA for a speciﬁc chemical and/or group. MOA
includes, in addition to the AOP, considerations of metabolism.
MOA analysis for species concordance additionally takes into
account chemical-speciﬁc absorption, distribution, metabolism
and elimination. It is anticipated, then, that increasingly, AOPs will
be developed that contribute to chemical-speciﬁc MOA analysis (as
one application) and vice versa.
1.6. Weight of evidence (WoE) for AOPs
Appropriately, given their conceptual similarity, consideration
of WoE for hypothesized AOPs draws upon a subset of the Bradford
Hill considerations as evolved from experience in MOA analysis
(Meek et al., 2014b; OECD, 2014; Becker et al., 2015). The subsetPlease cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10considered relevant to chemical agnostic AOPs include biological
plausibility and empirical support of KERs and essentiality of KEs.
These considerations, which are rank ordered in relation to their
relative contribution to weight of evidence/conﬁdence in the data
supporting a hypothesized AOP, are deﬁned and distinguished as
follows:
Biological Plausibility of KERs relates to how well we
understand the mechanistic structural/functional relationships
of the pathway. In essence, do we know enough to be able to
“predict” what happens if we disturb the pathway (experimental-
ly)?
Essentiality of KEs relates to experimental support for whether
or not downstream KEs or the AO are prevented or modiﬁed if an
upstream event is blocked. Experimental support includes, for
example, testing in knockout models or investigations of
reversibility.
Empirical Support relates to the nature of the expected
quantitative impact on downstream KEs if earlier KERs are
impacted and is normally tested by considering dose-response
relationships for stressors which impact the pathway.
More consistent evaluation of the weight of supporting
evidence for various components of the AOP based on these a
priori deﬁned considerations and associated examples of datasets
supporting high, moderate and low conﬁdence is anticipated to
facilitate consideration of documented AOPs for different potential
applications. It is also critical to explicitly identify critical data gaps
as a basis for facilitating targeted research and regulatory uptake.
Once evaluated, degrees of conﬁdence and associated rationales
are summarized as recommended by the OECD handbook (OECD,
2014). (See, also, for example, Yauk et al., 2015). The longer term
objective is to increase transparency and consistency in organizing,
linking and integrating information at different levels of biological
organization into a more efﬁcient, hypothesis-driven approach to
chemical data generation and assessment and to better tailor
development of mechanistic data to address regulatory needs.
Based on initial experience in assessing the supporting informa-
tion for hypothesized AOPs it is important to understand what type
of information is required in the context of regulatory purposes.
1.7. Challenges for developing AOPs relevant to neurotoxicity
evaluation
The brain is an extremely complex organ comprised of a variety
of highly specialized neuronal and glial cell types with multiple
and diverse cellular functions that differ between brain regions
and different stages of brain development (Rice and Barone, 2000).
Additionally, the function of molecules in the nervous system can
change as a function of developmental window, e.g., acetylcholin-
esterase promotes axonal growth and synapse formation of some
neuronal cell types in development but not in the adult brain, and
the role of gamma-aminobutyric acid (GABA) receptors switches
during development from excitatory to inhibitory (Jessell and
Sanes, 2000).
There are a variety of neuronal subtypes in the central and
peripheral nervous system that are characterized by the expression
of speciﬁc neurotransmitters neuronal receptors. Furthermore,
brain region-speciﬁc astrocytes and microglia play important roles
in neurophysiology (including structural functions, regulation of
metabolism and synapse formation) and the response to chemical
stressors (e.g, neuroprotective or neurotoxic function). In addition,
endothelial cells that form the blood-brain-barrier inﬂuence the
access of substances to the brain. These different cell types with
diverse functions represent a large number of potential targets for
neurotoxic chemicals, which implies the existence of a potentially
large number of AOPs with a variety of MIEs that when triggered
may lead to a range of different AOs.lying the adverse outcome pathway concept for understanding and
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system is a general lack of understanding of molecular and cellular
mechanisms of neurotoxicity, including mechanisms by which
chemicals interact with molecular targets. This reﬂects in part the
fact that many neurotoxicants can interact with multiple molecu-
lar targets. Therefore, it is unlikely that a single AO will be
produced for all chemicals that trigger the same MIE. Moreover,
even if the AOP is a simple linear progression from the MIE to AO,
the incidence of later KEs is expected to be less than that for early
KEs. Therefore, it is important to understand the key event
relationships (KERs) and to provide relevant information or, even
better, quantitative data supporting KERs, especially between the
early KEs.
There is a general lack of knowledge of a threshold (chemical
concentration and time of exposure) that triggers KE downstream
to a level that overcomes adaptive changes and compensating
mechanisms. Therefore, so far, the available AOPs relevant to adult
and developmental neurotoxicity are mainly qualitative, not
quantitative (Bal-Price et al., 2015b).
2. Evaluation of the scientiﬁc conﬁdence of the existing data for
development of the selected AOPs relevant for neurotoxicity
and developmental neurotoxicity
2.1. The acute neurotoxicity induced by binding of pyrethroid
insecticides to voltage-gated sodium channels
Synthetic pyrethroid insecticides have been utilized for nearly
ﬁve decades, and their toxicity to both insects and mammals is well
characterized. This class of compounds contains more than 20
different chemicals. Although all pyrethroids have common
structural characteristics (alcohol and acid moieties separated
by a central ester bond), they have a wide variety of different
structural characteristics and also exist as stereoisomers (Soder-
lund et al., 2002). The acute toxicity of these compounds has been
extensively studied and is well understood, which has allowed the
development of the recently published Adverse Outcome Pathway
for acute neurotoxicity through their binding to voltage-gated
sodium channels (Bal-Price et al., 2015b).
Brieﬂy, exposure to high doses of pyrethroid insecticides
produce signs and symptoms of one of two generalized syn-
dromes; Type I (or T) syndrome, which is characterized by tremor,
hyperexcitability, and Type II (or CS) syndrome, which is
characterized by choreoathetosis, excessive salivation, etc. The
Molecular Initiating Event of the AOP leading to these syndromes
begins with the pyrethroid binding to the alpha subunit of voltage-
gated sodium channels (VGSC), and subsequent modiﬁcation of the
kinetics of channel function, which ultimately leads to the two
toxicity syndromes described above.
To summarize, this AOP is comprised of the following KEs that
are initiated by binding of pyrethroids to the alpha subunit of the
VGSC (MIE): (1) changes in the kinetics of channel opening and
closing (KE 1); (2) alterations in excitability of neuronal
membranes (KE 2); (3) dysregulation of neural networks (KE 3);
(4) Behavioral changes associated with Type I and II poisoning
syndromes (Adverse Outcome).
A brief note about two unique aspects of this AOP. First,
depending on the compound, the modiﬁcations of VGSC kinetics in
KE2 can range from short-lived modiﬁcations (Type I compounds),
to very long lasting modiﬁcations (Type II compounds; reviewed
in: Soderlund et al., 2002). These modiﬁcations in KE1 inﬂuence
the response in KE2; type I compounds produce repetitive ﬁring of
action potentials, whereas Type II compounds produce membrane
depolarization, eventual depolarization-dependent block of action
potentials, and nerve terminal depolarization leading to excessive
neurotransmitter release. The MIE and KEs are causatively linkedPlease cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10to the ﬁnal adverse outcomes by structure-activity relationships
wherein Type I compounds typically lack an alpha cyano group and
produce short-term modiﬁcations of VGSC function and Type I
syndrome, whereas Type II compounds have a cyano group, cause
long-lasting modiﬁcation of VGSC kinetics, and cause Type II
syndrome. Second, although VGSCs are targets for modiﬁcation by
a number of different drugs, neurotoxicants and natural toxins, this
AOP is relatively narrowly deﬁned to apply to the pyrethroids and
DDT (which behaves as a type I pyrethroid). Other compounds
acting on VGSC bind to sites different than the pyrethroids,
produce different alterations of VGSC function and/or have
different clinical outcomes. Thus, separate AOPs need to be
described for these other compounds.
2.2. Evaluation of weight of evidence for this AOP
2.2.1. Biological plausibility for the identiﬁed Key Events Relationships
(KERs).
The biological plausibility of the KERs is strong and well
established, as VGSC are critical in the regulation of membrane
voltage and excitability and are integral to the initiation of the
neuronal action potential. The evidence for the binding to the alpha
submit of the VGSC (Molecular Initiating Event) is very strong and
supported by binding studies (Trainer et al., 1997), site-directed
mutagenesis studies (Vais et al., 2000: Rinkevich et al., 2013) and
X-ray crystallography (O’Reilly et al., 2006). However, despite this
well-established relationship, there are some notable uncertain-
ties. First, although two separate toxicity syndromes are described,
only a single AOP was proposed. This is because, although many
pyrethroid compounds fall neatly into one or the other categories,
several compounds exhibit, at the whole animal level, signs of both
the type I and II syndromes, and are referred to as “mixed”
pyrethroids. At the cellular level, the time course of modiﬁcation of
VGSC kinetics is not a bimodal distribution, but rather a continuum
from very short lasting modiﬁcations to very long lasting
modiﬁcations. Thus, the proposed AOP has one MIE: binding to
the alpha subunit of the VGSC. It does branch at the level of
modiﬁcation of VGSC kinetics, to account for the differences in
response seen at the level of the adverse outcome in the whole
animal.
2.2.2. Essentiality of the identiﬁed key events for AO (Type I and II
Toxicity Syndromes)
There are at least two clear indicators for the essentiality of the
identiﬁed KEs for the AO described above. First, as already
mentioned, the structure-activity relationships between Type I and
II compounds (presence or absence of the cyano group) and Type I
and II syndromes provides a clear indication of the linkage
between the KEs, KERs and the AO. Second, pyrethroids are chiral
compounds with as many as three chiral centers, and differences in
the toxicity of these compounds correlates with differences in the
ability of different stereoisomers to alter VGSC function and their
toxicity (Lund and Narahashi 1982). This supports further the
essentiality of the KEs leading to the AO.
It should be noted that the AOP as described (Bal-Price et al.,
2015b) uses the toxicity syndromes observed following pyrethroid
exposure as the Adverse Outcome. These are really a collection of
behaviors rather than a single adverse outcome, and not all
pyrethroid effects result in a “bimodal” behavioral response. For
example, both Type I and II compounds produce paresthesia
following dermal exposure (McKillop et al., 1987; Hudson et al.,
2014), and all pyrethroids inhibit motor activity following oral
exposure (Wolansky et al., 2006). In addition, there are several
uncertainties regarding the AOP, which have been hypothesized
based on pyrethroid actions on VGSC. These uncertainties include
the lack of an easily available biomarker for effect, the fact thatlying the adverse outcome pathway concept for understanding and
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data at the whole animal level. Of those subunits readily expressed
in the nervous system, it has been established that the rodent Nav
1.3, 1.6 and 1.8 isoforms of the alpha subunit of the VGSC are more
sensitive to pyrethroids than Nav 1.2 (Meacham et al., 2008; Tan
and Soderlund 2010). This information can be used to reﬁne the
AOP, along with considering more carefully which adverse
outcome one is trying to describe. For example, the Nav1.3 subunit
is highly (though not exclusively) expressed in the embryonic
period, thus exploration of potential developmental effects of
pyrethroids must consider the role of this channel during
development (see Shafer et al., 2005). By contrast, the Nav1.8
subunit is restricted in its expression to the peripheral nervous
system, including the small diameter neurons of the dorsal root
ganglion. Thus, an AOP for paresthesia could be described wherein
the MIE involves binding to the Nav1.8 VGSC in small diameter
sensory neurons of the dorsal root, and disrupting ﬁring properties
of these neurons, leading to the paraesthesias observed following
dermal exposure to pyrethroids. A similar approach to other
aspects of pyrethroid neurotoxicity (e.g. startle responses, motor
activity), will allow the deﬁnition of more speciﬁc AOPs and will
increase their utility. This concept can and should be applied to
other neurotoxic compounds. For example, “learning and memory”
is a broad category of behaviors, and more speciﬁc description of
the speciﬁc behavior altered (e.g. water maze learning) will allow
for better description of the neural pathways involved in that
behavior and clearer deﬁnition of the AOP.
2.3. Chronic antagonism of N-methyl-D-aspartate receptors
(NMDARs) during brain development induces impairment of learning
and memory abilities
The N-methyl-D-aspartate glutamate receptor (NMDAR) regu-
lates many critical neurodevelopmental processes, including
synaptogenesis and synaptic plasticity, both of which are
fundamental mechanisms of learning and memory (Traynelis
et al., 2010). Based on the existing literature, it is well documented
that binding of an antagonist to NMDAR during synaptogenesis
triggers a cascade of key events at the cellular and tissue level that
leads to impaired learning and memory. Therefore, in this AOP,
antagonism of the NMDA receptor has been identiﬁed as the MIE,
and impaired learning and memory is deﬁned as the AO.
Antagonism of the NMDA receptor by a chemical (for instance
by exposure to lead) triggers a cascade of causally linked cellular
KEs that result in cognitive deﬁcit. One of the initial KEs triggered
by inhibition of NMDAR is decreased inﬂux of calcium into the
neuron that inhibits calcium-dependent signaling. One conse-
quence of decreased intracellular calcium levels is reduced mRNA
expression and synthesis of brain derived neurotrophic factor
(BDNF) protein, which plays a fundamental role in neuronal
survival, development and differentiation, including synapto-
genesis. Decreased levels of BDNF are a fundamental cellular KE
that triggers neuronal apoptosis, aberrant dendritic morphology,
reduced presynaptic release of glutamate and decreased synapto-
genesis, resulting in decreased neuronal network function.
In summary, this AOP identiﬁes the following cascade of KEs:
(1) Binding of antagonist to NMDARs (MIE); (2) Inhibition of
NMDARs; (3) Reduced intracellular calcium levels; (4) Decreased
transcription of BDNF mRNA leading to reduce cellular levels of
BDNF; (5) Reduced presynaptic glutamate release, aberrant
dendritic morphology and increased neuronal apoptosis; (6)
Decreased synaptogenesis; (7) Decreased neuronal network
function; (8) Impaired learning and memory (AO).
Here, we focus on the evaluation of two fundamental features of
the AOP WoE evaluation: biological plausibility and essentiality of
the described KERs.Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.102.4. Evaluation of weight of evidence for this AOP
2.4.1. Biological plausibility for the identiﬁed Key Events Relationships
(KERs)
The supporting evidence for the biological plausibility of the
relationship between the Inhibition of NMDARs by binding of an
antagonist (KE upstream) and Decreased calcium inﬂux (KE
downstream) is strong. There is structural and functional
mechanistic understanding supporting this relationship. The
inhibition of NMDARs leads to closure of the central ion channel
pore and consequently reduction in Ca2+ inﬂux. The function of
NMDA receptors is commonly evaluated by measuring intracellu-
lar inﬂux of Ca2+, therefore, calcium imaging techniques have been
extensively utilized to investigate the relationship between these
two KEs (Higley and Sabatini, 2012). For example, the NMDA-
mediated increase in Ca2+ was absent in brain slices from GluRe2/
 mice that do not possess functional NMDA receptors in the
developing neocortex (Okada et al., 2003), suggesting that NMDAR
activation was responsible for Ca2+ inﬂux.
Decreased Ca2+ inﬂux (KE upstream) triggers Reduced release
of BDNF (KE downstream). There is extensive scientiﬁc under-
standing of the mechanistic relationship between these two KEs.
BDNF transcription is induced by Ca2+ entering in the neurons
through either L-type voltage gated calcium channels (L-VGCC)
(Tao et al., 1998) or the NMDAR (Tabuchi et al., 2000; Zheng
et al., 2011). Ca2+ binds to and activates the transcription factor
cAMP-response element binding protein (CREB). Additional
transcription factors implicated in the transcription of BDNF
include NFAT (nuclear factor of activated T cell), MEF2 (myocyte
enhancer factor 2) and NFkB (nuclear factor kB) (reviewed
in Zheng et al., 2012). The initial activation of CaM kinase,
cAMP/PKA and Ras/ERK1/2 pathways mediated by the elevated
intracellular Ca2+ triggers activation of other transcription factors
and inhibition of different elements of these pathways has been
shown to decrease BDNF mRNA and protein levels (reviewed in
Zheng et al., 2012).
Reduced release of BDNF (KE upstream) triggers the following
downstream KEs: Reduced presynaptic glutamate release, Aberrant
dendritic morphology and Increased apoptosis. There is extensive
scientiﬁc understanding of the mechanistic relationship between
these KEs. Stimulation of tyrosine kinase B (TrkB) receptors by
BDNF leads to the activation of proteins such as Arc, Homer2,
LIMK1 (Kang and Schuman, 1996; Schratt et al., 2004; Yin et al.,
2002) that are known to promote actin polymerization and
consequently the enlargement of dendritic spine heads (Sala et al.,
2001). Furthermore, it has been shown that the inhibition of BDNF
synthesis reduces the size of spine heads and impairs long term
potentiation (LTP) (Ahn et al., 2008a; Ahn et al., 2008b; Water-
house and Xu, 2009). Experimentally, it has been shown that
activation of presynaptic TrkB receptors by BDNF also enhances
glutamate release and increases the frequency of excitatory
postsynaptic current (EPSCs) in hippocampal neurons derived
from rat (Lessmann and Heumann, 1998; Takei et al., 1998;
Minichiello, 2009). In addition, BDNF inﬂuences apoptosis of
developing neurons through two distinct mechanisms (Bernd,
2008). mBDNF can trigger pro-survival signaling after binding to
TrkB receptor, which subsequently inactivates speciﬁc compo-
nents of the cell death machinery while also activating the
transcription factor CREB, which drives expression of the pro-
survival gene Bcl-2 (West et al., 2001). On the other hand, proBDNF
binds to the p75 neurotrophin receptor (p75NTR) and activates
RhoA that regulates actin cytoskeleton polymerization resulting in
apoptosis (Lee et al., 2001; Miller and Kaplan, 2001; Murray and
Holmes, 2011).
It is well documented that BDNF mRNA levels dramatically
increase between embryonic days 11–13 of rat development, andlying the adverse outcome pathway concept for understanding and
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differentiation (reviewed in Murray and Holmes, 2011). Taking into
consideration these important BDNF functions in the developing
brain, a reduced level of BDNF (KE upstream) induced by binding of
an antagonist to the NMDAR results in KE downstream, Decreased
synaptogenesis leading to Decreased neuronal network function that
are fundamental processes for learning and memory. Indeed, the
ability of a neuron to communicate is based on neural network
formation that relies on functional synapse establishment (Colon-
Ramos, 2009). The main roles of synapses are the regulation of
intercellular communication in the nervous system, and the
information ﬂow within neural networks. The connectivity and
functionality of neural networks depends on where and when
synapses are formed. Therefore, the decreased synapse formation
during the process of synaptogenesis is critical and leads to
decrease of neural network formation.
Decreased neuronal network function (KE upstream) leads to
Impairment of learning and memory (KE downstream, AO). Learning
and memory is dependent on neuronal network function.
Learning-induced enhancement in neuronal excitability, a mea-
surement of neural network function, has been shown in
hippocampal neurons following classical conditioning in several
experimental approaches (reviewed in Saar and Barkai, 2003).
Furthermore, memory requires increased magnitude of EPSCs to be
developed quickly and to be persistent for several weeks at least
without disturbing already potentiated contacts (reviewed in
Lynch, 2004).
2.5. Essentiality of the identiﬁed key events for AO (Impairment of
learning and memory)
1) The evidence for the essentiality of the MIE (Binding of
antagonist to NMDAR in neurons during synaptogenesis in
hippocampus and cortex) for AO (Impairment of learning and
memory) is evaluated as strong since it is well documented that
learning and memory processes rely on physiological functioning
of NMDA receptors. Their essential role has been demonstrated in
both animal and human studies investigating NMDA itself, NMDA
receptor antagonists and mutant mice lacking NMDA receptor
subunits (reviewed in Haberny et al. (2002); Rezvani (2006) and
Granger et al. (2011)).
2) Essentiality of the KE: Inhibition of NMDA receptors
Evidence for the essentiality of this KE for the AO is suggested to
be strong since the noncompetitive antagonist MK-801 has been
shown to induce dose-dependent impairment of learning and
memory (Wong et al., 1986) and data from rodent models
conﬁrmed these effects, as recently reviewed by van der Staay
et al. (2011). Similarly, NMDA receptor blockage has been reported
to impair learning in nonhuman primates (Ogura and Aigner,
1993). Moreover, human studies demonstrate that NMDA-receptor
inhibition impairs learning and memory processes (reviewed in
Rezvani, 2006).
3) Essentiality of the KE: Decreased Calcium inﬂux
Based on the existing data, evidence for the essentiality of
Decreased Calcium inﬂux for AO (Impairment of learning and
memory) is determined to be strong. In the nervous system, many
intracellular responses are mediated by calcium/calmodulin-
regulated protein kinases (CaMKs), followed by protein phosphor-
ylation (Wayman et al., 2008). Multifunctional CaMKs, such as
CaMKII and members of the CaMK signaling cascade (CaMKK,
CaMKI and CaMKIV), are highly abundant in the CNS where they
regulate different protein substrates (Soderling, 1999). For
instance, mice with a mutation in the alpha-CaMKII that is
abundantly found in the hippocampus have shown spatial learning
impairments, whereas some types of non-spatial learning pro-
cesses have not been affected (Silva et al., 1992).Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.104) Essentiality of KE: Decreased levels of BDNF
Evidence for the essentiality of this KE for the AO is determined
to be strong. BDNF serves essential functions in brain development
and, more speciﬁcally, in synaptic plasticity (Poo, 2001), and is
crucial for learning and memory processes (Lu et al., 2008). The
action of BDNF signaling on synapses via sustained TrkB activation
happens within seconds of its release (Kovalchuk et al., 2004), and
this action strengthens LTP processes, a cellular model for learning
and memory (Kang and Schuman, 1996; Nagappan and Lu, 2005).
Furthermore, there is experimental evidence showing that loss of
BDNF via genetic deletion or pharmacological manipulation
impairs LTP (Patterson et al., 1996; Monteggia et al., 2004) and
decreases learning and memory (Lu et al., 2008).
5) Evidence for the essentiality of Decreased presynaptic release
of glutamate (caused by reduced release of BDNF) for the AO is
determined to be strong. The role of glutamate and different
glutamatergic receptor subtypes in learning and memory process-
es is well understood based on the existing psychopharmacological
in vivo studies conducted in rodents and primates (for example
Riedel et al., 2003; Redini-del-Negro and Laroche, 1993). Similarly,
support for the essentiality of the KE: Aberrant dendritic
morphology caused indirectly by BDNF for the AO (Impairment of
learning and memory) is determined to be strong. Spine morphol-
ogy is considered to be an important morphological unit for
establishing learning and memory (Sekino et al., 2007). As
dendrites are the postsynaptic site of most synaptic contacts,
dendritic development determines the number and pattern of
synapses received by each neuron (McAllister, 2000). Defects in
dendritic growth are associated with severe neurodevelopmental
disorders such as mental retardation (Purpura, 1975). Thus, the
proper growth and arborization of dendrites is crucial for proper
functioning of the nervous system, and changes in spine formation
are implicated in impaired learning and memory (Yang et al.,
2009b; Roberts et al., 2010).
6) Essentiality of the KE: Decreased synaptogenesis
Support for the essentiality of the KE (Decreased synaptogenesis)
for the AO (Impairment of learning and memory) is also determined
to be strong. Learning and memory result from synaptic plasticity
that modiﬁes the way neurons communicate with each other (Bear,
1996). Plasticity is deﬁned as changes in the structure, distribution
and/or number of synapses, and it has been suggested that these
changes underlie memory formation (Rusakov et al., 1997; Woolf,
1998; Klintsova and Greenough, 1999). In mutant mice lacking
PSD-95 (post-synaptic protein), increased NMDA-dependent LTP
has been recorded that severely impairs spatial learning (Migaud
et al., 1998). Furthermore, recent genetic screening in human
subjects as well as neurobehavioral studies in transgenic mice have
suggested that loss of synaptophysin (a presynaptic vesicle
protein) plays an important role in mental retardation and
learning deﬁcits (Schmitt et al., 2009; Tarpey et al., 2009).
7) Essentiality of the KE: Decreased function of neuronal network
It is well understood and documented that the ability of
neurons to communicate with each other is based on neural
network formation that relies on functional synapse establishment
(Colon-Ramos, 2009). The connectivity and functionality of neural
networks depends on where and when synapses are formed.
Therefore, decreased synapse formation during the process of
synaptogenesis is detrimental and leads to decrease of neural
network formation and function. Alterations in synaptic connec-
tivity underlie the reﬁnement of neuronal networks during
development (Cline and Haas, 2008). Indeed, knockdown of
PSD-95 (postsynaptic protein) blocks the functional and morpho-
logical development of glutamatergic synapses (Ehrlich et al.,
2007).
This AOP is applicable for speciﬁc period of brain development
that corresponds to the time of synaptogenesis, which occurs atlying the adverse outcome pathway concept for understanding and
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period of synaptogenesis starts during the third trimester of
pregnancy and continues until 2–3 years following birth (Bai et al.,
2013). Furthermore, synaptogenesis does not happen at the same
time across all brain regions and there are important differences in
the ontogenetic expression proﬁles of excitatory versus inhibitory
synapses (Erecinska et al., 2004).
Most of the evidence supporting the proposed AOP was
generated from studies (in vitro, in vivo and epidemiological)
following exposure to lead. Any chemicals that block NMDAR
activity could trigger the described MIE and could potentially be
chemical initiators for this AOP. However, there is a gap of
knowledge in these type of studies as only very few chemicals have
been evaluated for their effects on DNT effects (Grandjean and
Landrigan, 2006; Bal-Price et al., 2015a) and an even smaller subset
of these have been screened for effects on the NMDAR activity.
2.6. Sensitization of the ryanodine receptor (RyR) in the developing
brain alters synaptic connectivity leading to neurobehavioral
perturbations
RyRs are microsomal Ca2+-induced Ca2+ ion channels that are
expressed by neurons in multiple regions of the mammalian brain.
RyRs associate with cytosolic, endoplasmic reticulum (ER)
membrane-anchored and ER luminal proteins to form local Ca2+
release units that regulate Ca2+ release from the ER and modify
gating responses of plasma membrane ion channels, including
NMDA receptors and voltage-gated Ca2+ channels (Pessah et al.,
2010). It has been demonstrated that diverse chemicals can
interact with the RyR to enhance its sensitivity to activation by
nanomolar levels of Ca2+ and decrease its sensitivity to inhibitory
feedback by millimolar Ca2+ and Mg2+ (Pessah et al., 2010; Pessah
and Wong, 2001). This sensitization of the RyR stabilizes the
channel in its open conformation, which increases release of Ca2+
from the endoplasmic reticulum thereby increasing intracellular
Ca2+ levels (Berridge, 2006; Pessah et al., 2010).
Changes in intracellular Ca2+ are a principal mechanism by
which neuronal activity regulates diverse neurodevelopmental
processes (Lohmann and Wong, 2005; Segal et al., 2000; Wayman
et al., 2008) that are critical determinants of synaptic connectivity,
including dendritic arborization (Libersat and Duch, 2004; Scott
and Luo, 2001), dendritic spine formation and apoptosis (Barone
et al., 2000; Martin, 2001; Sastry and Rao, 2000). The importance
of neuronal activity in reﬁning patterns of synaptic connectivity in
the developing brain (Katz and Shatz, 1996; Yuste and Bonhoeffer,
2001) is evidenced by the marked effect of experience on the
development and reﬁnement of synaptic connections, which not
only patterns neural circuitry during development but also
underlies associative learning (Pittenger and Kandel, 2003).
Altered patterns of synaptic connectivity are widely postulated
to be the neurobiological substrate for many neurodevelopmental
disorders, including autism spectrum disorders (ASD), attention
deﬁcit hyperactivity disorder (ADHD) and various intellectual
disabilities (Bourgeron, 2009; Geschwind and Levitt, 2007; Judson
et al., 2011; Penzes et al., 2011; Zoghbi and Bear, 2012).
In this AOP, sensitization of neuronal RyRs is identiﬁed as the
molecular initiating event (MIE) and neurobehavioral perturba-
tions as the adverse outcome (AO). This AOP is largely derived from
mechanistic studies of the non-dioxin-like PCB congener PCB 95.
PCB 95 potently sensitizes the RyR (Wong et al., 1997a; Wong and
Pessah, 1996), which triggers a cascade of key cellular events that
ultimately modulate neurodevelopmental processes that inﬂuence
synaptic connectivity in the developing brain, speciﬁcally dendritic
arborization, dendritic spine formation and neuronal apoptosis
(Howard et al., 2003; Lesiak et al., 2014; Wayman et al., 2012a)
thereby altering patterns of synaptic connectivity (Lein et al., 2007;Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10Yang et al., 2009a; Yang and Lein, 2010a). These altered patterns of
synaptic connectivity underlie neurobehavioral perturbations.
In summary, the following sequence of KEs are proposed
downstream of RyR sensitization (MIE): (1) Increased intracellular
Ca2+ levels (KE1); (3) Activation of Ca2+-dependent signaling
pathways (KE2); (4) Increased dendritic arborization, increased
dendritic spine formation and increased neuronal apoptosis (KE3);
(4) Neurobehavioral deﬁcits including social deﬁcits and impaired
learning and memory (AO).
2.7. Evaluation of the weight of evidence supporting this AOP:
2.7.1. Biological plausibility for Key Events Relationships (KERs)
Evidence for the biological plausibility of a mechanistic
relationship between the sensitization of neuronal RyRs (KE
upstream) and increased intracellular Ca2+ levels (KE downstream)
is extremely strong. RyRs are functionally deﬁned as Ca2+-induced
Ca2+ ion channels, and RyR activity is often assessed by measuring
Ca2+ ﬂux across membranes or lipid bilayers (Pessah et al., 2010;
Van Petegem, 2015). Studies across multiple laboratories have
shown that sensitization of neuronal RyRs, which increases their
open probability, results in increased neuronal levels of intracel-
lular Ca2+ levels [reviewed in (Pessah et al., 2010; Van Petegem,
2015)]. Consistent with this mechanistic relationship, PCB 95 has
been shown to stabilize RyR1 in the open state by both cryo
electron microscopy (Samso et al., 2009) and 3[H]-ryanodine
binding (Pessah et al., 2006), and exposure to PCB 95 results in
increased intracellular Ca2+ levels in PC12 cells (Wong et al., 2001),
primary hippocampal neurons (Wayman et al., 2012a) and cortical
microsomes (Wong et al., 1997a).
Increased intracellular Ca2+ levels (KE upstream) results in
activation of Ca2+-dependent signaling pathways (KE downstream).
There is extensive scientiﬁc understanding of the mechanistic
relationship between these two KEs (Berridge, 1998; Konur and
Ghosh, 2005; Redmond and Ghosh, 2005; Wayman et al., 2008).
Particularly relevant to this AOP are studies demonstrating a causal
link between increased intracellular Ca2+ levels and sequential
activation of CaMKK, CaMKI and MEK/ERK to activate the
transcription factor CREB, which then upregulates transcription
of Wnt2 (Wayman et al., 2006) and miR132 (Impey et al., 2010).
Elevated intracellular Ca2+ has also been causally linked to the
activation of signaling pathways that trigger neuronal apoptosis
(Berridge et al., 2000; Ermak and Davies, 2002; Ravagnan et al.,
2002; Robertson et al., 2001). The biological plausibility between
these two KEs is further supported by studies of the gain-of-
function missense mutation in the L-type Ca2+ channel CaV1.2 that
causes Timothy syndrome, which has a 60% rate of co-morbidity
with autism (Splawski et al., 2004). Neurons differentiated from
induced pluripotent stem cells derived from Timothy syndrome
patients revealed increased Ca2+ oscillations and upregulated
expression of genes linked to Ca2+-dependent regulation of CREB,
including CaMK (Pasca et al., 2011).
There is extensive scientiﬁc evidence to support the biological
plausibility of a mechanistic relationship between activation of
Ca2+-dependent signaling pathways (KE upstream) and increased
dendritic arborization, increased dendritic spine formation and
increased neuronal apoptosis (KEs downstream). Ca2+ imaging
studies have demonstrated that increased intracellular Ca2+ in
neurons coincides with increased growth of dendrites and dendritic
spines (Lohmann and Wong, 2005), while mechanistic studies in
primary neuronal cell cultures provide compelling evidence
that the growth of dendrites and dendritic spines are mediated
by Ca2+-dependent signaling pathways [reviewed in (Konur and
Ghosh, 2005; Lohmann, 2009; Redmond and Ghosh, 2005; Valnegri
et al., 2015; Wayman et al., 2008)]. A speciﬁc Ca2+-dependent
signaling pathway has been linked to activity-dependent dendriticlying the adverse outcome pathway concept for understanding and
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activation of CaM-dependent protein kinase kinase (CaMKK),
CaMKI, the Ras/MEK/ERK signaling pathway and the transcription
factor CREB resulting in upregulation of Wnt-2, which acts in an
autocrine manner to stimulate dendritic growth (Wayman et al.,
2006). This Ca2+-dependent signaling pathway was causally linked
to dendritic growth by demonstrating that pharmacological
blockade or genetic suppression of any single molecule in this
signaling cascade blocked not only activation of downstream
signaling molecules in the cascade, but also activity-dependent
dendritic growth; conversely, expression of constitutively active
forms of key molecules in the signaling pathway phenocopied the
effects of activity on dendritic arborization.
Similar pharmacological blockade and siRNA knockdown
approaches demonstrated that dendritic spine formation in
primary hippocampal neurons is triggered by a Ca2+-dependent
signaling pathway involving CREB-mediated upregulation of
miR132, which suppresses the translation of p250GAP, a negative
regulator of synaptogenesis (Impey et al., 2010). Morphological
characterization of dendritic spines in a doxycycline-regulated
miR-132 transgenic mouse strain to drive varying levels of
transgenic miR-132 expression, conﬁrmed that miR132 function
is required for activity-dependent spine formation in hippocampal
neurons in vivo (Hansen et al., 2013). Different Ca2+-dependent
signaling pathways have been implicated in triggering neuronal
apoptosis (Berridge, 2006; Colomer and Means, 2007; Li et al.,
2014; Liu et al., 2013).
Further supporting the biological plausibility of a mechanistic
link between activation of Ca2+-dependent signaling pathways (KE
upstream) and increased dendritic arborization, increased dendritic
spine formation and increased neuronal apoptosis (KEs downstream)
are data showing that miR132 represses expression of methyl-
CpG-binding protein-2 (MeCP2) (Klein et al., 2007). MeCP2 is a
transcriptional repressor, and disruption of its function results in
signiﬁcant dendritic and synaptic dysregulation (Zhou et al., 2006).
MeCP2 knockout animals have signiﬁcantly perturbed synthesis
and release of brain-derived neurotrophic factor (BDNF), a
neurotrophic factor that stimulates dendritic outgrowth and
synaptogenesis (Jin et al., 2003; Rex et al., 2007; Wang et al.,
2006). Dysfunction of MeCP2 has been implicated in signiﬁcant
cognitive impairment in experimental models and humans, and
both mutations and duplications of the gene have been associated
with Rett syndrome and autism spectrum disorders (Cukier et al.,
2012; LaSalle and Yasui, 2009; Percy, 2011). miR132 has also been
shown to interact with fragile X mental retardation protein (FMRP)
to regulate synapse formation in experimental models (Edbauer
et al., 2010), and more recently, expression of miR132 has been
shown to be dysregulated in schizophrenia (Kim et al., 2010; Miller
et al., 2012), a disorder characterized by aberrant synaptic pruning
(Woo, 2014).
Support for the biological plausibility of a mechanistic
relationship between increased dendritic arborization, dendritic
spine formation and/or neuronal apoptosis (KE upstream) and
neurobehavioral perturbations (KE downstream) is strong. Altered
patterns of dendritic growth and plasticity are associated with
impaired behavior in experimental models (Berger-Sweeney and
Hohmann, 1997) and are the most consistent pathological
correlates of functional deﬁcits in intellectual delay and neuro-
psychiatric disorders (Belmonte and Bourgeron, 2006; Bourgeron,
2009; Delorme et al., 2013; Penzes et al., 2011). The types of
aberrations observed in post mortem samples of patients included
abnormalities in the number, size and branching patterns of
dendrites as well as changes in the density or shape of dendritic
spines. Strong support for a mechanistic relationship between
these KEs is provided by experimental studies using a doxycycline-
regulated miR-132 transgenic mouse strain to drive varying levelsPlease cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10of transgenic miR-132 expression. miR132 activity, which is
required for activity-dependent spine formation in vitro and in
vivo, also regulates cognitive behavior in rodent models (Hansen
et al., 2013; Hansen et al., 2010). Interestingly, these in vivo studies
indicate that while miR132 is required for cognitive function,
overexpression of miR132 to supra-physiological levels compro-
mises cognitive function coincident with signiﬁcantly increased
spine formation (Hansen et al., 2013). While dendritic arborization
and dendritic spine density are often positively correlated with
cognitive capacity, histological studies of brains from patients
diagnosed with autism spectrum disorders (Hutsler and Zhang,
2010), or fragile X syndrome (Irwin et al., 2001) have revealed
signiﬁcantly increased spine densities in neurons relative to
neurotypical controls. Similarly, functional MRI studies have
shown an association between local functional hyperconnectivity
and symptom severity in autism spectrum disorders (Keown et al.,
2013). Such data suggest that hyperconnectivity may be as
disruptive to normal cognitive function as hypoconnectivity. There
is experimental evidence that increased neuronal apoptosis may
also contribute to neurobehavioral deﬁcits (Barone et al., 2000;
Rice and Barone, 2000). Indeed, it is believed that removal of even a
small number of postmitotic neurons during synaptogenesis can
signiﬁcantly alter patterns of connectivity, resulting in functional
deﬁcits in the absence of obvious pathology (Dikranian et al., 2001;
Ikonomidou et al., 1999; Martin, 2001; Martin and Green, 1995).
2.8. Essentiality of the identiﬁed MIE for KE and AO
In the following sections, we discuss the evidence for the
essentiality of the MIE, RyR sensitization, for each of the KEs and AO.
This analysis is largely derived from experimental studies of PCB
developmental neurotoxicity.
(1) Essentiality of RyR sensitization (MIE) for increased intracellular
Ca2+levels (KE1): Strong evidence supports a causal relation-
ship between the MIE and this KE. A subset of non-dioxin-like
(NDL) PCBs signiﬁcantly increase RyR sensitivity to activation
by nanomolar Ca2+ and attenuate their sensitivity to inhibitor
feedback by millimolar Ca2+ and Mg2+ (Pessah et al., 2006;
Pessah and Wong, 2001). Structure activity relationship studies
reveal that non-coplanar NDL PCBs possessing 2-3 chlorine
ortho substitutions are the most potent RyR sensitizers, with
PCB 95 being the most potent and efﬁcacious congener
identiﬁed to date (Pessah et al., 2010; Pessah et al., 2006).
Two lines of evidence conﬁrm a causal link between RyR
sensitization (MIE) and increased intracellular Ca2+levels (KE): (i)
the effect of PCB 95 is blocked by treatment with ryanodine at
concentrations that inhibit RyR activity (Wayman et al.,
2012a); and (ii) PCB 66, a congener with negligible effect on
RyR activity, has no effect on neuronal Ca2+ ﬂuxes.
(2) Essentiality of RyR sensitization (MIE) for activation of Ca2
+-dependent signaling pathways (KE2): The evidence in support
of a causal link between this MIE and KE is strong. Exposure of
primary hippocampal neurons to the RyR active PCB 95, but not
the RyR-inactive congener PCB 66, activates CaMKK, CaMKI,
MEK/ERK and CREB and upregulates expression of Wnt2 mRNA
(Wayman et al., 2012a). PCB 95 activation of the CaMKI-CREB-
Wnt2 signaling pathway is blocked by pharmacological
antagonism of RyRs using FLA 365 or siRNA knockdown of
RyR1 or RyR2 (Wayman et al., 2012a). In rat primary
hippocampal cultures, the potent RyR sensitizer PCB 95 also
stimulates miR132 upregulation via CREB-dependent mecha-
nisms, and suppresses translation of p250GAP (Lesiak et al.,
2014). PCB 95 effects on these signaling molecules are blocked
by pharmacological antagonism of RyRs using FLA 365 or by
siRNA knockdown of RyR1 or RyR2 (Lesiak et al., 2014).lying the adverse outcome pathway concept for understanding and
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arborization, increased dendritic spine formation and increased
neuronal apoptosis (KE3): Strong evidence supports a causal
link between the MIE and these KEs. The potent RyR sensitizer
PCB 95, but not the RyR-inactive congener PCB 66, enhances
dendritic arborization in primary cortical (Yang et al., 2009a,b)
and hippocampal cell cultures (Wayman et al., 2012a), and the
dendrite promoting activity of PCB 95 is blocked by pharma-
cological antagonism of RyRs using FLA 365 or siRNA
knockdown of RyR1 or RyR2 (Wayman et al., 2012b; Yang
et al., 2009a,b). PCB 95 has also been shown to promote
dendritic growth via RyR-dependent mechanisms in rat
hippocampal slice cultures (Wayman et al., 2012b). Consistent
with the proposed link between the MIE and this KE,
gestational and lactational exposure to Aroclor 1254 increases
dendritic arborization of cerebellar Purkinje cells (Lein et al.,
2007; Yang et al., 2009a,b) and pyramidal neurons in both the
neocortex (Lein et al., 2007; Yang et al., 2009a,b) and CA1
hippocampus (Wayman et al., 2012b) of juvenile rats.
RyR activity has also been implicated in mediating dendritic
spine formation. Local release of Ca2+ from intracellular stores,
which is regulated in part by RyR activity, increases the size of
dendritic spines (Korkotian and Segal, 1999), and RyR-inhibitory
concentrations of ryanodine block BDNF-enhanced spine forma-
tion in primary hippocampal neurons (Adasme et al., 2011).
Consistent with these observations, proteomic studies have
demonstrated that RyR-active PCBs increase expression of synaptic
proteins in rat cerebellar neurons (Brunelli et al., 2012). Functional
evidence is also consistent with a causal link between RyR
sensitization and increased dendritic spine formation. Dendritic
spines are the primary site of excitatory synaptic input in the brain
(Segal, 2005), and PCB 95, but not PCB 66, increases excitability in
hippocampal slice cultures (Wong et al., 1997b), and increases the
ratio of excitatory to inhibitory neurotransmission in hippocampal
slice cultures, an effect blocked by the RyR antagonist dantrolene
(Kim et al., 2009). In vivo studies provide further support of this
link: developmental exposure to PCB 95 increases the ratio of
excitatory to inhibitory neurotransmission in the developing rat
auditory cortex (Kenet et al., 2007).
Experimental evidence causally links RyR sensitization to
neuronal apoptosis. Increased RyR activity (Andjelic et al., 1997;
Danieli and Rampazzo, 2002; Hajnoczky et al., 2000; Mariot et al.,
2000; Pan et al., 2000) and intracellular Ca2+ (Berridge et al., 2000;
Ermak and Davies, 2002; Ravagnan et al., 2002) are critical
components of apoptotic signaling pathways. Aroclor 1254, a
mixture comprised of predominantly NDL PCBs (Kostyniak et al.,
2005), as well as the RyR-active NDL congener PCB 47 signiﬁcantly
increase caspase-dependent apoptosis in primary hippocampal
cultures (Howard et al., 2003). The pro-apoptotic activity of PCB 47
is inhibited by the RyR antagonist FLA 365 but not by antagonists of
the IP3 receptor (xestospongin C), L-type calcium channel
(verapamil), or NMDA receptor (APV) (Howard et al., 2003).
Further, PCB 77, a congener with little to no RyR activity, has no
effect on apoptosis in primary hippocampal neurons (Howard
et al., 2003). In vivo data are consistent with the proposed
relationship between the MIE and increased neuronal apoptosis.
Gestational and lactational exposure to Aroclor 1254 exposure at
1 mg/kg/day in the maternal diet increased caspase 3 activity in the
hippocampus, cortex and cerebellum of newborn but not weanling
rats (Yang and Lein, 2010), an observation conﬁrmed by TUNEL
staining (Yang and Lein, 2010). Collectively, these results provide
strong evidence of causal links between RyR sensitization and
neuronal apoptosis.
(4) Essentiality of RyR sensitization (MIE) for neurobehavioral
perturbations (AO): The evidence of the relationship between RyRPlease cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10sensitization and neurobehavioral perturbations do not conﬁrm
causality. As discussed above, experimental studies of the
developmental neurotoxicity of PCBs have established causal links
between RyR sensitization and effects on dendritic arborization,
dendritic spine formation and neuronal apoptosis in vitro and
shown associations between these endpoints in vivo. The most
compelling data of a causal link between the MIE and AO are in vivo
studies demonstrating that the effects of gestational and
lactational exposure to Aroclor 1254 on RyR activation, as assessed
by 3[H]-ryanodine binding, dendritic arborization, as measured by
Golgi staining, and deﬁcits in spatial learning and memory as
determined using the Morris water maze, demonstrated a similar
non-monotonic dose-response relationship (Yang et al., 2009a,b).
Independent studies have similarly shown that gestational and
lactational exposure to Aroclor 1254 impairs radial-arm maze
performance in adult male rats (Roegge et al., 2000) at doses
shown to increase RyR activity in the cerebellum (Roegge et al.,
2006). A major caveat of these studies using Aroclor 1254 with
respect to this AOP is that while Aroclor 1254 is comprised
predominantly of NDL PCBs with RyR activity, there are additional
congeners in this technical mixture that have little to no effect on
RyR activity (Kostyniak et al., 2005). However, developmental
exposure to PCB 95 at low doses (0.1–1 mg/kg/day in maternal diet)
similarly increases dendritic arborization of CA1 pyramidal
neurons in the hippocampus of juvenile rats (Wayman et al.,
2012b). While this latter study did not assess behavioral function,
independent studies have demonstrated that perinatal exposure to
PCB 95 altered activity levels and behavior in the radial arm maze
in adult rats (Schantz et al., 1997) and enhanced the ratio of
excitatory to inhibitory currents within the primary auditory
cortex of juvenile rats (Kenet et al., 2007). Also supportive of this
AOP are data showing that perinatal exposure to RyR-active PCB 47,
albeit in combination with PCB 77, a congener with no effect on
RyR activity, alters social behavior in rats (Jolous-Jamshidi et al.,
2010).
A number of in vivo studies have failed to show effects of
developmental exposure to PCBs on dendritic arborization and/or
behavior (Bushnell and Rice, 1999; Roegge et al., 2006; Roegge and
Schantz, 2006). However, these seeming discrepancies may
actually be consistent with the proposed AOP. For example, some
negative studies [e.g., (Bushnell and Rice, 1999)] focused on PCB
congeners, such as PCB 126, that have negligible effect on RyR
activity (Pessah et al., 2006). Other studies that failed to ﬁnd an
effect of developmental Aroclor 1254 exposure on dendritic
arborization (e.g., Roegge et al., 2006; Roegge and Schantz,
2006) may be explained by the fact that these studies tested
doses at the high end or even higher than the dose range studied by
Lein and colleagues (Wayman et al., 2012b; Yang et al., 2009a,b;
Yang and Lein, 2010) who reported that the dose-response
relationship for Aroclor 1254 effects on RyR activity, dendritic
growth and plasticity and spatial learning and memory exhibited a
non-monotonic dose-response relationship (Yang et al., 2009a,b).
Much of the evidence used to support the proposed AOP was
generated from studies of Aroclor 1254, a technical mixture of both
RyR-active and RyR-inactive PCB congeners (Kostyniak et al.,
2005), or the potent RyR sensitizer, PCB 95. Recent studies have
shown that another NDL congener, PCB 136, also sensitizes RyRs,
and this molecular interaction has been causally linked to
enhanced synchronized Ca2+ oscillations and increased dendritic
arborization in primary hippocampal neurons (Yang et al., 2014).
RyR activity is modulated by a diverse set of chemicals (Xu et al.,
1998), and there is growing evidence that chemicals other than
PCBs, many of which also have non-coplanar structures, can
sensitize and/or activate the RyR. Several examples include
caffeine (Pessah et al., 1987), polybrominated diphenyl ethers
(PBDEs) (Kim et al., 2011), triclosan (Ahn et al., 2008a,b) andlying the adverse outcome pathway concept for understanding and
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compounds trigger the same downstream key events as RyR-active
PCBs has not been directly or rigorously evaluated. However, the
available published literature suggests that at least a subset of
these structurally diverse RyR active compounds phenocopy key
events triggered by RyR-active PCBs. For example, developmental
exposure to caffeine increased dendritic length and branching in
the rat prefrontal cortex (Juarez-Mendez et al., 2006), and has been
shown to increase caspase-3 activation in multiple brain regions
(Black et al., 2008). In vitro exposure to caffeine also activated CREB
and CREB-dependent gene expression in mouse cortical neurons
(Connolly and Kingsbury, 2010). PBDEs, a class of halogenated
ﬂame retardants, sensitize RyRs via interactions with the FKBP12/
RyR complex and this molecular effect was causally linked to
enhanced Ca2+ oscillations and increased neuronal network
activity (Kim et al., 2011). Developmental exposure to PBDEs has
also been shown to impair cognitive and motor behavior in rodent
models (Dufault et al., 2005; Suvorov et al., 2009; Ta et al., 2011).
Triclosan, an antimicrobial agent, and suramin, an antiparasitic
drug, also sensitize RyRs (Ahn et al., 2008a,b; Papineni et al., 2002).
As predicted by the proposed AOP, triclosan induced apoptosis in
cultured mouse cortical neurons via activation of Ca2+-dependent
caspases (Szychowski et al., 2015). Suramin decreased cell viability
in neuronal cell lines and mouse primary neuronal cultures (Guo
et al., 1990) and these neurotoxic effects were modulated by
calcium inﬂux (Sun and Windebank, 1996). Whether these RyR
active chemicals interfere with neuronal connectivity in the
developing brain to produce behavioral deﬁcits, and whether these
events are RyR-dependent remains to be determined. In conclu-
sion, while limited, these data support the possibility that the
proposed AOP may be relevant to diverse chemical structures.
2.9. Description of the putative AOP: disrupted laminin-b1-integrin
interaction leading to developmental neurotoxicity
The extracellular matrix (ECM) is a structural element that
plays a prominent role in neurodevelopment and maturation of
neural circuits (Lubbers et al., 2014) as it can inﬂuence cell
adhesion, survival, proliferation, migration, and differentiation
(Tzu and Marinkovich 2008). Interactions between the ECM
protein laminin and integrin receptors represent a speciﬁc ECM-
cell interaction that regulates many key aspects of neurodevelop-
ment (Belvindrah et al., 2007; Graus-Porta et al., 2001; Lubbers
et al., 2014; Warren et al., 2012). For example, selective loss of b1-
integrin in excitatory neurons or in all brain cells leads to impaired
hippocampus-dependent learning (Warren et al., 2012) or defec-
tive radial glia anchoring during cortical formation (Graus-Porta
et al., 2001), respectively. Therefore, in this putative AOP, the
disruption of laminin interactions with the b1-integrin has been
identiﬁed as the MIE that triggers a series of KEs leading to
impaired learning as the postulated AO. Chemicals that bind to the
ECM protein laminin and thereby mask the laminin-b1-integrin
binding site are suggested to disrupt important cellular processes
necessary for brain development including cell adhesion, cell
orientation and cell migration thereby resulting in improper
cortical development. This putative AOP has been hypothesized
based on the case study of Epigalloctechin gallate (EGCG), a
ﬂavonoid commercialized as a food supplement. EGCG disrupts the
cell-ECM binding of Neural Progenitor Cells (NPCs), thereby
disturbs their adhesion, induces chaotic orientation of GFAP+
(glial ﬁbillary acidic protein) astrocytes processes and reduces
migration as well as cellular density of NPCs in the neurosphere
migration area (Barenys et al., in press). Due to these properties,
EGCG is studied as a model compound for this AOP.
In summary, this putative AOP is composed of the following
KEs: (MIE) binding of compound to laminin; (KE1) interference ofPlease cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10the laminin-b1-integrin binding; (KE2) disturbed adhesion; (KE3)
chaotic cell orientation; (KE4) altered migration; (KE5) decreased
cell density; (AO) impairment of learning based on studies with
transgenic animals.
The generation of this putative AOP was initiated by basic
research observations from screening studies applying the ‘Neuro-
sphere Assay’ for developmental neurotoxicity testing (Baumann
et al., 2014; Baumann et al., 2015). The experimental data
supporting the early KE and their relationships of this AOP are
detailed in our primary publication describing the effects of EGCG
on cell migration in the neurosphere assay (Barenys et al., in press).
Based on these experimental data, here we aim to evaluate the
biological plausibility and essentiality of the identiﬁed KEs to
assess the general weight of evidence of this still very preliminary,
putative AOP. This example illustrates the usefulness of imple-
menting the AOP concept in basic toxicological research applica-
tions, as a basis to generate data of potential utility in regulatory
application.
2.10. Evaluation of weight of evidence for this AOP
2.10.1. Biological plausibility for the identiﬁed Key Events
Relationships (KERs)
The MIE of this AOP is described by the binding of the model
compound EGCG to the ECM protein laminin. Laminin is a major
component of brain ECM and it is critical for normal brain function
(Chen et al., 2009). That EGCG has the ability to bind to laminin is
supported by two studies from two independent laboratories: an
afﬁnity chromatography study using columns (Suzuki and Isemura
2001) and a binding study (Lo et al., 2007). Our data provides
additional evidence that bindingof EGCG to the ECM is the MIEof this
putative AOP since EGCG effects on NPCs are observed only under
experimental conditions in which the ECM laminin is exposed to
EGCG, but not under conditions in which the NPCs are treated with
EGCG in the absence of laminin (Barenys et al., in press).
This compound binding to laminin results in KE1: interference
with the function of b1-integrin receptors of NPCs. The
relationship between the MIE and KE1 is supported by the
observation that in salivary gland adenocarcinoma cells and in the
human monocyte cell line THP-1, EGCG prevents b1-integrin
activation (Melgarejo et al., 2009; Park et al., 2010). Our own
results also show that EGCG antagonizes soluble laminin binding
to b1-integrin (Barenys et al., in press).
The MIE and KE1 cause decreased adhesion of NPCs in vitro
(KE2; Barenys et al., in press). Faulty adhesion of radial glia not
forming correct glia endfeet is also observed in developing brains
of mice lacking the b1-integrin subunit speciﬁcally in NPCs (CNS-
(nestin-Cre)-b1-integrin-deﬁcient mice) supporting the role of b1-
integrin for glia cell adhesion during brain development (Graus-
Porta et al., 2001). EGCG binding to laminin also disturbs cell
adhesion in melanoma cells (Bracke et al., 1987; Suzuki and
Isemura 2001) reinforcing this KER by studies in a different cell
type. Decreased ECM adhesion of NPC causes chaotic process
orientation of GFAP+ cells differentiated from NPCs (KE3) (Barenys
et al., in press). That this de-alignment of radial glia processes is
due to interference with b1-integrin function is also supported by
in vivo studies with mice lacking the b1-integrin subunit in NPCs
(CNS-(nestin-Cre)-b1-integrin-deﬁcient mice). Besides faulty glial
cell adhesion, these cells meander chaotically through parts of the
developing brain (Graus-Porta et al., 2001). This phenotype of
chaotic glia processes is still maintained ex vivo when nestin-Cre-
b1-integrin-deﬁcient cells are transferred into a culture dish
(Belvindrah et al., 2007). These in vivo and ex vivo studies
demonstrate the importance of b1-integrin for proper cell
adhesion and thus support the KER that chemical interference
with their function alter brain development.lying the adverse outcome pathway concept for understanding and
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GFAP+ cells (KE3) triggers an alteration in the migration pattern of
NPCs (KE4) which leads to decreased cell density in the migration
area (KE5). The alterations in the migration phenotype (KE4) are
only observed when the laminin coated slides (laminin ECM) are
exposed or pre-exposed to EGCG and not when the human NPCs
are preexposed to the compound and plated in unexposed laminin
(Barenys et al., in press), supporting the relationship between the
MIE and KE4. EGCG interference with migration of rat NPCs was
observed earlier (Chen et al., 2003). Moreover, migration studies
exposing human NPCs to a functionally blocking b1-integrin
antibody reproduces the same phenotype than EGCG on migrating
human NPCs (Barenys et al., in press), adding more evidence to
support the relationship between KE1 and KE4. A causal link
between KE1 and KE4 is also supported by studies with smooth
muscle cells in which migration was inhibited by EGCG in a
concentration-dependent manner through interference with
b1-integrin receptor binding to ECM proteins (Lo et al., 2007).
A concentration-dependent decrease in cell density in the
migration area (KE5) is observed in vitro after exposure of NPCs to
EGCG (Barenys et al., in press). To evaluate the organ responses
within this AOP, we performed neurohistological analyses for
BrdU+ cells in rats after developmental exposure to EGCG in vivo, to
monitor neuronal migration into the cortex as previously
described in Kakita et al., 2002 and Trentini et al., 2016. Offspring
of exposed animals had a lower density of 5-bromo-2-deoxyur-
idine positive cells in cortical layers after high dose exposure
during development (Barenys et al., unpublished data). Similarly,
mice lacking the b1-integrin subunit in neural precursor cells
(CNS-(nestin-Cre)-b1-integrin-deﬁcient mice) present ‘less tightly
packed’ cells in cortical layers (Graus-Porta et al., 2001). It is well
documented that b1-integrin function during development is
important to maintain the integrity of the glial scaffold (Manent
et al., 2011).
There is currently no data on a compound-induced AO for this
AOP available. However, b1-integrin deﬁcient animals display
behavioral abnormalities. When b1-integrin is lacking in excitato-
ry neurons, hippocampus-dependent learning is impaired (Warren
et al., 2012). These Nex-Cre (itgb1ﬂox/ﬂox Nex-Cre+) mice display a
behavioral phenotype; they fail to discriminate between novel and
familiar objects in a hippocampus-dependent novel object
recognition task (Warren et al., 2012).
2.11. Essentiality of the identiﬁed key events for AO (impairment of
learning and memory)
This AOP clearly displays the knowledge gap on compound
exposure and AO. While the hypothetical AO explained above is
based on experiments with transgenic animals that lack the
b1-integrin protein, so far there has been no study performed with
a compound that disrupts the binding of laminin to b1-integrins.
Therefore, essentiality of the KE for the AO cannot be assessed.
However, the in vitro data in combination with the existing data as
described above suggest that there is concern for a potential
developmental neurotoxicity hazard by the proposed MOA. Clearly,
more data is needed to substantiate this concern.
The experimental data used to support the proposed AOP was
obtained from studies on developmental exposure to EGCG or from
studies with mice lacking the b1-integrin subunit in neural
precursor cells or excitatory neurons. Other catechins containing
galloyl/pyrogallol groups (Epigallocatechin: EGC, and epicatechin
gallate: ECG) also inhibit human NPCs adhesion to laminin,
suggesting that chemicals with similar structure can trigger the
same key events (Barenys et al., in press). This is in agreement with
previous observations from Lo et al. (2007) demonstrating that
both EGCG and ECG were able to inhibit cell adhesion on laminin.Please cite this article in press as: A. Bal-Price, et al., Developing and app
predicting neurotoxicity, Neurotoxicology (2016), http://dx.doi.org/10.10There is a need of more information about the ability of other
compounds from different chemical families to trigger the same
cascade of key events.
2.12. Potential relevance of the described, putative AOPs to current risk
assessments
The potential of AOPs to support various regulatory and
research applications is related to their completeness, and
conﬁdence in the underlying information (and extent of its
documentation). The even incomplete AOPs provide an organizing
construct for further incorporation of biological knowledge for
potential applications. Early consideration of the extent of support
and resulting conﬁdence in various elements of hypothesized AOPs
promotes better common understanding between the research
and regulatory communities as a basis to facilitate application.
The extent of conﬁdence required in supporting information for
AOPs varies as a function of intended application as addressed in
formal problem formulation (Meek et al., 2014a; OECD, 2013, 2015;
Patlewicz et al., 2015; Perkins et al., 2015). Different applications to
which AOPs can contribute, include: 1) supporting chemical
category formation and “read-across”; 2) screening and priority
setting for further testing; 3) hazard identiﬁcation; 4) classiﬁcation
and labeling; 5) identifying research priorities and designing
integrated testing strategies (ITS) or integrated approaches to
testing and assessment (IATA); and 6) risk assessment. Necessarily,
chemical speciﬁc information on exposure, metabolism and
toxicokinetics (i.e., MOA analysis) and quantitation relevant to
dose-response analysis is also taken into account to varying
extents in these different applications. Within the context of IATA,
AOPs have potential to increase conﬁdence of decisions in any of
these contexts (Meek et al., 2008; OECD, 2013, 2015; Patlewicz
et al., 2015; Perkins et al., 2015).
Some examples of potential applications of the AOPs presented
here are included below. The least developed AOP, which is applied
for research gap and priority identiﬁcation on the level of academic
research is the AOP Disrupted laminin-b1-integrin interaction
leading to developmental neurotoxicity. This AOP is an excellent
example illustrating the value of the AOP organizing construct
concept in basic toxicological research. Identiﬁcation of critical KEs
of this AOP has guided research design, which may facilitate
consideration in any regulatory context
The AOP entitled The Acute Neurotoxicity induced by binding to
Voltage-Gated Sodium Channels contributed to the cumulative
chemical speciﬁc mode of action based assessment for pyrethroid
insecticides that was conducted under the Food Quality Protection
Act (FQPA), Brieﬂy, the US Environmental Protection Agency had to
determine whether or not to consider risks associated with
exposure to all pyrethroid insecticides collectively, or to separately
consider risks of Type I from Type II pyrethroids based on the
different syndromes of toxicity (AOs). It was also proposed that
some compounds (mostly Type II compounds) also had separate
MOA based on modiﬁcation of voltage-gated calcium channels
(Shafer and Meyer 2004; Clark and Symington 2012) and a “maxi”
chloride channel (Forshaw et al., 2000; Burr and Ray, 2004).
However, the Agency determined that there was not enough
evidence to warrant using these latter two potential MOA, and that
although there are different syndromes of pyrethroid neurotoxici-
ty, only one MOA underlies these syndromes (e.g. they have a
common AOP).
More recently, the AOP concept has been utilized to make
predictions about the sensitivity of different ecological species to
the toxicity of pyrethroid insecticides. Lalone et al. (2013)
compared the similarity of VGSC alpha subunits and the sensitivity
(LC50) of different ecological species; this could be used to predict
the sensitivity of a given species (e.g. an endangered species) whenlying the adverse outcome pathway concept for understanding and
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that species is impractical or impossible.
The AOP entitled Chronic binding of antagonist to N-N-methyl-D-
aspartate receptors (NMDARs) during brain development induces
impairment of learning and memory abilities is relevant to
developmental neurotoxicity since it refers to a deﬁned window
of brain development when synaptogenesis takes place that is a
key developmental process involved in learning and memory,
deﬁned in this AOP as an AO. Similarly, learning and memory
deﬁcit is also postulated as a possible AO of the putative AOP
entitled Disrupted laminin-b1-integrin interaction leading to devel-
opmental neurotoxicity and an AOP on Sensitization of the ryanodine
receptor (RyR) in the developing brain alters synaptic connectivity
leading to neurobehavioral perturbations.
Throughout the years, a signiﬁcant number of methods has
been developed to assess neurobehaviorial change in laboratory
animals, including impairment of learning and memory (OECD
Guidance Document for Neurotoxicity Testing, 2004). This
endpoint is important mainly for developmental neurotoxicity
(DNT), for which there is a wide variety of tests to assess chemical
effects on cognitive functions. Some of these tests are: habituation,
ethologically based anxiety tests (elevated plus maze test, black
and white box test, social interaction test), conditioned taste
aversion (CTA), active avoidance, passive avoidance, spatial mazes
(Morris water maze, Biel water maze, T-maze), conditional
discrimination (simple discrimination, matching to sample),
delayed discrimination (delayed matching-to-sample, delayed
alternation) and eye-blink conditioning. Learning and memory
tests are required by the OECD Test Guideline for Developmental
Neurotoxicity (426), the OECD Test Guideline for Combined
Repeated Dose Toxicity Study with Reproduction/Developmental
Toxicity Screening Test (422) and the OECD Test Guideline for
Extended One-Generation Reproductive Toxicity Study (443).
AOPs such as those described here can potentially contribute to
the development of a mechanistically informed IATA for evaluation
of chemicals with DNT potential, including those that cause
impairment of learning and memory. Potentially, identiﬁcation of
common KEs and KERs that emerge among the available AOPs
interconnected within a network can inform concerning assays
that could potentially be informative in IATA to address the most
critical pathways of toxicity involved in DNT.
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